Evidence map›Paper›PMID 37570786›Full record

ArticleMolecules (Basel, Switzerland)2023

Omprakash Mohanta, Asit Ray, Sudipta Jena, Ambika Sahoo, Soumya Swarup Panda, Prabhat Kumar Das, Sanghamitra Nayak, Pratap Chandra Panda

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Omprakash MohantaCentre for Biotechnology, Siksha 'O' Anusandhan (Deemed to be University), Kalinga Nagar, Bhubaneswar 751003, India.ORCID 0000-0002-0757-9612
Asit RayCentre for Biotechnology, Siksha 'O' Anusandhan (Deemed to be University), Kalinga Nagar, Bhubaneswar 751003, India.ORCID 0000-0002-6111-9529
Sudipta JenaCentre for Biotechnology, Siksha 'O' Anusandhan (Deemed to be University), Kalinga Nagar, Bhubaneswar 751003, India.ORCID 0000-0003-4770-6185
Ambika SahooCentre for Biotechnology, Siksha 'O' Anusandhan (Deemed to be University), Kalinga Nagar, Bhubaneswar 751003, India.ORCID 0000-0002-5016-3735
Soumya Swarup PandaCentre for Biotechnology, Siksha 'O' Anusandhan (Deemed to be University), Kalinga Nagar, Bhubaneswar 751003, India.ORCID 0000-0002-7628-0948
Prabhat Kumar DasCentre for Biotechnology, Siksha 'O' Anusandhan (Deemed to be University), Kalinga Nagar, Bhubaneswar 751003, India.ORCID 0000-0001-9844-9380
Sanghamitra NayakCentre for Biotechnology, Siksha 'O' Anusandhan (Deemed to be University), Kalinga Nagar, Bhubaneswar 751003, India.ORCID 0000-0001-9038-261X
Pratap Chandra PandaCentre for Biotechnology, Siksha 'O' Anusandhan (Deemed to be University), Kalinga Nagar, Bhubaneswar 751003, India.ORCID 0000-0002-4902-7453
Siksha O Anusandhan University · IN

Funding

Department of Science and Technology DST/INSPIRE Fellowship/2019/IF190495
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

NF-kappa BOils, VolatileAnimalsAnti-Inflammatory AgentsCytokinesInflammationLipopolysaccharidesMacrophagesMiceOxidative StressRAW 264.7 CellsSignal TransductionAnti-Inflammatory AgentsCytokinesLipopolysaccharidesNF-kappa BOils, Volatileanti-inflammatoryessential oillipopolysaccharideMesosphaerum suaveolensNF-κB pathwayRAW 264.7 cells

Identifiers

PMID37570786
PMCPMC10420984
OpenAlexW4385491456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.